The effectiveness and tolerability of switching Indian patients from sacubitril/valsartan, ARNI to perindopril in heart failure with reduced ejection fraction. [Efficient study]

par Pankaj Jariwala, Kartik Jadhav
Publié 2021

Unexpected use of ‘additional-stent’ during elective percutaneous coronary intervention

par Kartik Jadhav, Pankaj Jariwala
Publié 2021

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study

par Pankaj Jariwala, Kartik Jadhav
Publié 2021

The use of modern techniques in percutaneous coronary intervention for bifurcation lesions: A single centre experience

par Pankaj Jariwala, Kartik Jadhav
Publié 2021

The safety and efficacy of efonidipine, an L- and T-type dual calcium channel blocker, on heart rate and blood pressure in Indian patients with mild-to-moderate essential hypertens...

par Pankaj Jariwala, Kartik Jadhav, Saket Khetan
Publié 2021

The safety and efficacy of fimasartan in Indian patients with systemic arterial hypertension

par Pankaj Jariwala, Kartik Jadhav, Saket Khetan
Publié 2021

The clinical experience of macitentan in pulmonary hypertension in Indian cohort: 12-months follow-up

par Pankaj Jariwala, Kartik Jadhav, Saket Khetan, Maturu Nagarjuna
Publié 2021